Losartan Potassium Tablets — Class II drug recall D-0895-2023
Terminated recall by Strides Pharma Inc., reported 2023-07-12, distributed nationwide. Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
| Recall number | D-0895-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Strides Pharma Inc., East Brunswick, NJ, United States |
| Recall initiated | 2023-06-26 |
| Classified | 2023-07-06 |
| Reported by FDA | 2023-07-12 |
| Terminated | 2024-05-15 |
| Distributed | Nationwide (US) |
| Quantity | 2,700 hdpe |
| NDC | 64380-0933, 64380-0933-04, 64380-0933-05, 64380-0933-08, 64380-0934, 64380-0934-04, 64380-0934-05, 64380-0934-08, 64380-0935, 64380-0935-04, 64380-0935-05, 64380-0935-08 |
| Lot numbers | 7901903A |
| Expiration dates | 2024-04 |
Product
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08
Reason for recall
Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0895-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.